Researchers analyzed EHR data from more than 73 million patients across the country, spanning 360 hospitals and 317,000 clinicians.
Results indicated that a recent cancer diagnosis was strongly linked to increased risk of COVID-19, with an adjusted odds ratio of 7.14. Those diagnosed with leukemia, non-Hodgkin lymphoma and lung cancer within the past year faced the greatest COVID-19 risk, with 12.16, 8.54 and 7.66 adjusted odds ratios, respectively. Thyroid cancer posed the least risk for COVID-19 with an odds ratio of 3.10.
Overall, Black patients with a recent cancer diagnosis were more likely to contract a COVID-19 infection than white patients. Black patients with a recent breast cancer diagnosis faced an odds ratio of 5.44, posing the greatest risk among common cancers. Cancer patients who also had COVID-19 had higher hospitalization and death rates than cancer-free COVID-19 patients and cancer patients without COVID-19.
Strategies to increase protection among this vulnerable group should be considered as a way to address these findings, the study said.
More articles on oncology:
UC Health taps AI to detect lung nodules
St. Peter’s Health asks court to dismiss lawsuit over oncologist’s removal
UPMC cancer center gets National Cancer Institute designation renewal
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
